Clinical trial

Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

NCT04370665

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusCOMPLETED
Study typeINTERVENTIONAL
Start date2020-07-16
PhaseNA
Advertisement

Sponsors & collaborators

InSighteclead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.